Helicobacter pylori therapy: First-line options and rescue regimen

Digestive Diseases

Volumn 19, Issue 2, 2001, Pages 134-143

  Gisbert, Javier P ^a,b   Pajares, José María ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b NONE   (Spain)

Author keywords

Esomeprazole; Helicobacter pylori; Lansoprazole; Omeprazole; Pantoprazole; Rabeprazole; Ranitidine bismuth citrate

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH DERIVATIVE; CLARITHROMYCIN; ESOMEPRAZOLE; METRONIDAZOLE; NITROIMIDAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE BISMUTH CITRATE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; DYSPEPSIA; ERADICATION THERAPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; ULCER HEALING;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; PENICILLINS; PEPTIC ULCER; PROTON PUMPS; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 0034853463     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050668     Document Type: Review

References (87)

1. Efficacy of lansoprazole in eradicating Helicobacter pylori: A meta-analysis
2. Treatment for the eradication of Helicobacter pylori: Recommendations of the Spanish Consensus Conference
3. Therapy: The year in Helicobacter pylori
4. One week triple therapy for Helicobacter pylori: A multicentre comparative study
5. Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: The prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence
6. Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection
7. Effectiveness of omeprazole-amoxicillin-clarithromycin (OAC) therapy for Helicobacter pylori infection in a Japanese population
8. Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: A pilot study
9. Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population
10. Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection - Comparison with omeprazole and lansoprazole
11. Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy
12. Pantoprazole, azithromycin and tinidazole: Short duration triple therapy for eradication of Helicobacter pylori infection
13. Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy
14. Five-day triple therapy in Helicobacter pylori-positive duodenal ulcer: An eighteen-month follow-up
15. Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: Comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole
16. Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy
17. Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection
18. 5-Day vs. 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication
19. Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection
20. Rabeprazole, amoxicillin and low- or high-dose clarithromycin for cure of Helicobacter pylori infection
21. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: Results of three US multicenter, double-blind trials
22. One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease
23. Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: A review
24. Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer
25. One-week use of ranitidine bismuth citrate, amoxicillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer
26. Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication
27. Helicobacter pylori-positive duodenal ulcer: Three-day antibiotic eradication regimen
28. The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori
29. Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus
30. Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: A multicentre, randomized, single-blind study
31. Omeprazole or ranitidine bismuth citrate triple therapy to treat Helicobacter pylori infection: A randomized, controlled trial in Vietnamese patients with duodenal ulcer
32. One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance
33. One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication
34. Review article: Treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies
35. Helicobacter pylori eradication: Proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week - A meta-analysis of efficacy
36. Ranitidine bismuth citrate can help to overcome Helicobacter pylori resistance to clarithromycin in vivo
37. Omeprazole plus amoxicillin for cure of Helicobacter pylori infection: Factors influencing the treatment success
38. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers
39. Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients?
40. Pretreatment with pantoprazole affects the efficacy of a modern triple therapy in H. pylori cure?
41. Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: A controlled trial versus omeprazole plus amoxicillin
42. Previous treatment with omeprazole and H. pylori: Does it diminish the eradication efficacy of the 'new' triple therapies of one week's duration?
43. One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers
44. One week low-dose H. pylori eradication therapy heals 90% of duodenal ulcers
45. Short-term triple therapy of pantoprazole, clarithromycin and metronidazole for cure of H. pylori infection and cure of peptic ulcer disease
46. Duodenal ulcer healing after 7-day treatment: A pilot study with lansoprazole, amoxicillin and clarithromycin
47. Low-dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers
48. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing
49. Is 1-week treatment for peptic ulcer healing sufficient and safe?
50. Does eliminating Helicobacter pylori mean the healing of the duodenal ulcer? The results of a prospective study in Spain
51. Unhealed duodenal ulcers despite Helicobacter pylori eradication
52. Does eradication of Helicobacter pylori alone heal duodenal ulcers?
53. The impact of Helicobacter pylori eradication on peptic ulcer healing
54. Is there any difference in Helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia?
55. Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia?
56. Duodenal ulcer and functional dyspepsia: Different susceptibility of Helicobacter pylori to eradicating therapy
57. Efficacy and tolerability of a seven-day triple scheme with pantoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori
58. Efficacy of PPI-triple therapy in H. pylori positive patients with ulcer disease versus patients with non-ulcer dyspepsia
59. Different Helicobacter pylori eradication rates between non-ulcer dyspepsia and peptic ulcer patients
60. Efficacy of one week pantoprazole containing triple therapies for eradication of Helicobacter pylori
61. Is PPI-triple therapy of greater efficacy in peptic ulcer than in non-ulcer dyspeptic patients
62. Does the efficacy of eradication treatment with OCA-7 decrease in non-ulcer gastroduodenal disease?
63. Failure of Helicobacter pylori therapy: Disparity between duodenal ulcer and non-ulcer dyspepsia
64. A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China
65. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia
66. Omeprazole plus antibiotics in the eradication of Helicobacter pylori infection: A meta-regression analysis of randomized, controlled trials
67. Are one-week anti-H. pylori treatments more effective in patients with peptic ulcer disease (PUD) than in those with non-ulcer dyspepsia (NUD)? A meta-analysis
68. Is there a difference in eradication rate of Helicobacter pylori between peptic ulcer patients and non-ulcer dyspepsia patients? A survey of 1,666 patients
69. Current European concepts in the management of Helicobacter pylori infection: The Maastricht Consensus Report
70. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection
71. Efficacy of a multistep strategy for Helicobacter pylori eradication: Quadruple therapy with omeprazole, metronidazole, tetracycline and bismuth after failure of combination of omeprazole, clarithromycin and amoxycillin
72. A practical approach to patients with refractory Helicobacter pylori infection, or who are reinfected after standard therapy
73. Regular review: Treatment of Helicobacter pylori infection
74. Proton pump inhibitor, clarithromycin and either amoxicillin or nitroimidazole: A meta-analysis of eradication of Helicobacter pylori
75. Treatment after failure: The problem of 'non-responders'
76. Eficacia de dos tratamientos consecutivos en la erradicación de Helicobacter pylori
77. Re-treatment after Helicobacter pylori eradication failure
78. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice
79. Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: A detailed, prospective analysis of 21 consecutive cases
80. High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy
81. Randomized study comparing omeprazole with ranitidine as anti-secretory agents combined in quadruple second-line Helicobacter pylori eradication regimens
82. Randomized study of two 'rescue' therapies for Helicobacter pylori-infected patients after failure of standard triple therapies
83. Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: Omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole
84. Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy
85. 'Rescue' therapy including ranitidine bismuth citrate and minocycline and amoxicillin for failure
86. Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens
87. Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment: Preliminary experience